CHROMENONE COMPOUNDS AS PI3-KINASE INHIBITORS FOR TREATING CANCER Russian patent published in 2016 - IPC C07D413/14 C07D417/14 A61K31/5377 A61K31/541 A61P35/00 

Abstract RU 2598028 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to chrome neon compounds with formula I possessing properties of PI3-kinase enzymes inhibitor or its pharmaceutically acceptable salts, pharmaceutical compositions based on them. In general formula I R1 represents C1-4alkyl, possibly substituted hydroxy; R2 represents C1-4alkyl; or R1 and R2 form together 4-6-member nitrogen-containing heterocyclic ring system which optionally contains 1 additional heteroatom selected from oxygen and sulphur, where sulphur ring atom is optionally oxidated with formation of S-oxide(-s), where said ring is possibly substituted with hydroxy; R3 and R5 are independently selected from H, halogen, C1-3alkoxy and cyano; R4 represents H or fluorine; n equals to 0 or 1.

EFFECT: prevention and treatment of tumours sensitive to inhibition of PI3-kinase enzymes.

15 cl, 4 dwg, 3 ex, 1 tbl

Similar patents RU2598028C2

Title Year Author Number
NOVEL TETRAZOLONE DERIVATIVES 2014
  • Greter Uve
  • Nettekofen Mattias
  • Pyullmann Bernd
  • Refer Shtefan
  • Rodzhers-Evans Mark
  • Shults-Gash Tanya
RU2664644C2
PYRIMIDYL CYCLOPENTANES AS AKT-PROTEIN KINASE INHIBITORS 2008
  • Benksik Jozef R.
  • Blehjk Dzhejms F.
  • Kallan Nikolas K.
  • Mitchell Jan S.
  • Spenser Kit L.
  • Ksiao Dengming
  • Ksu Rui
  • Chabot Kristin
  • Liang Dzun
  • Safina Brajn S.
RU2486178C2
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR 2017
  • Zhu Li
  • Hu Yuandong
  • Wu Wei
  • Dai Liguang
  • Duan Xiaowei
  • Yang Yanqing
  • Sun Yinghui
  • Han Yongxin
  • Peng Yong
  • Kong Fansheng
  • Luo Hong
  • Yang Ling
  • Xu Hongjiang
  • Guo Meng
  • Wang Shanchun
  • Zhong Zhaobai
RU2764523C2
PYRAZINE COMPOUNDS AND THEIR USE 2019
  • Qi Changhe
  • Tsui Honchung
  • Zeng Qingbei
  • Yang Zhenfan
  • Zhang Xiaolin
RU2809631C2
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS 2016
  • Wenglowsky Steven Mark
  • Brooijmans Natasja
  • Miduturu Chandrasekhar V.
  • Bifulco Neil
RU2744974C2
OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS 2019
  • Bell, Charlz
  • Bents, Jerg
  • Gobbi, Luka
  • Greter, Uve
  • Grebke Tsbinden, Katrin
  • Khansen, Dennis Zhyul
  • Khornsperger, Benua
  • Kotser, Byulent
  • Kroll, Karsten
  • Kun, Bernd
  • O'Khara, Fionn
  • Rikhter, Khans
  • Ritter, Martin
  • Tsutiya, Satosi
  • Chen, Zhuj
RU2794334C2
SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD 2010
  • Ivashchenko Aleksandr Vasil'Evich
  • Bychko Vadim Vasil'Evich
  • Mit'Kin Oleg Dmitrievich
RU2452735C1
MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH 2019
  • Praefke, Bent
  • Klefekorn, Filip
  • Zelig, Roland
  • Albrekht, Volfgang
  • Laufer, Shtefan
RU2788000C2
TRIAZOLPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER 2019
  • Goldberg Frederick Woolf
  • Ting Attilla Kuan Tsuei
  • Lamont Gillian Mcgregor
  • Buttar David
  • Kettle Jason Grant
RU2793249C2
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS 2013
  • Chern Tszi-Van
  • Dzhagtap Atszit Dkhanandzhej
  • Van Khsyao-Chun
  • Chen Grejs Shiakhu
RU2627706C2

RU 2 598 028 C2

Authors

Barlaam Bernard Christophe

Degorce Sebastien Louis

Lambert-Van Der Brempt Christine Marie Paul

Lohmann Jean-Jacques Marcel

Ple Patrick

Dates

2016-09-20Published

2012-04-12Filed